When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
FOMX - Foamix Pharmaceuticals' FDA Application Accepted For Review Catalyst Laid Out Ahead
Foamix Pharmaceuticals Ltd.
Foamix Pharmaceuticals (FOMX) announced that the FDA had accepted its application for review of its topical foam drug FMX103 to treat patients with moderate-to-severe papulopustular rosacea in adults. This opens up the opportunity for the biotech to possibly receive approval for this large market. The second news item that came out recently also was that the FDA had approved FMX101 to treat patients with moderate to severe acne. With an FDA approved product, I expect the stock price to trade higher in the coming months
NDA Accepted for FMX103 For Treatment Of Papulopustular